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Background: Right ventricular (RV) function is an important determinant of outcome in patients with heart failure. We utilized data from the 
MADIT-CRT trial to determine whether therapy with CRT is influenced by or affects right ventricular function.
Methods: 1820 patients were randomly assigned to CRT plus ICD (CRT-D) or ICD only in a 3:2 ratio. We assessed RV function as right ventricular 
fractional area change (RVFAC) by echocardiography at baseline (n=1511) and after one year of therapy (n=1273). We assessed the relationship 
between baseline RVFAC and response to therapy, and compared changes in cardiac size, performance and outcomes.
Results: Patients with RVFAC <35% had the worst response to treatment (hazard ratio for treatment effect 0.83, 95% CI 0.42, 1.63) compared 
with those with RVFAC≥35% (hazard ratio 0.58, 95% CI 0.46, 0.74). Randomization to CRT-D was associated with a greater improvement in RVFAC 
(8.1%±5.4% versus 5.4% ±4.8%, p<0.01). Lower RVFAC at one year was associated with higher event rates (10.1% per year in the lowest quartile 
versus 5% per year in the highest quartile).
Conclusions: Although CRT improves right ventricular function, patients with the worst right ventricular function at baseline derive the least 
treatment benefit from CRT. Improvement in RV function was associated with improved outcomes. 
